Healthcare - Biotechnology - NASDAQ - US
$ 0.754
0.533 %
$ 29.8 M
Market Cap
-1.57
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
33.97%
Net Income
Estimate
24.04%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
MiNK Therapeutics, Inc.
INKT has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart INKT
EBIT FORECAST
EBIT Forecast Chart INKT
NET INCOME FORECAST
Net Income Chart INKT